Literature DB >> 2128459

Exercise tolerance after anaemia correction with recombinant human erythropoietin in end-stage renal disease.

E Baraldi1, G Montini, S Zanconato, G Zacchello, F Zacchello.   

Abstract

The aim of this study was to evaluate the effect of correction of chronic anaemia on the physical performance and the cardiovascular response to effort in children with end-stage renal disease (ESRD) maintained by haemodialysis. Seven patients (mean age 13.9 years) underwent triangular-type treadmill exercise testing before [haemoglobin (Hb) 6.3 +/- 0.9 g/dl] and after (Hb 11.2 +/- 1.2 g/dl) anaemia correction with recombinant human erythropoietin (rHuEPO). After treatment, the work-load reached, the peak oxygen uptake and average ventilatory anaerobic threshold (VAT) values were significantly increased (P less than 0.01, P less than 0.001, P less than 0.05 respectively). VAT values, expressed as a percentage of normal values, increased from 55.7 +/- 16.6% to 82.4 +/- 21%. This improvement correlated well with the increase in Hb (r = 0.79). Oxygen pulse also increased significantly, when tested after anaemia correction. In conclusion, these data demonstrate that when the anaemia of children with ESRD is corrected with rHuEPO, there is a clear improvement in aerobic work capacity and effort tolerance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128459     DOI: 10.1007/bf00858638

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  17 in total

1.  Is ventilatory anaerobic threshold a good index of endurance capacity?

Authors:  P Vago; J Mercier; M Ramonatxo; C Prefaut
Journal:  Int J Sports Med       Date:  1987-06       Impact factor: 3.118

2.  Anaerobic threshold and respiratory gas exchange during exercise.

Authors:  K Wasserman; B J Whipp; S N Koyl; W L Beaver
Journal:  J Appl Physiol       Date:  1973-08       Impact factor: 3.531

3.  Exercise capacity in hemodialysis, CAPD, and renal transplant patients.

Authors:  P Painter; D Messer-Rehak; P Hanson; S W Zimmerman; N R Glass
Journal:  Nephron       Date:  1986       Impact factor: 2.847

Review 4.  Exercise in end-stage renal disease.

Authors:  P Painter; S W Zimmerman
Journal:  Am J Kidney Dis       Date:  1986-05       Impact factor: 8.860

5.  Exercise tolerance in patients on chronic hemodialysis.

Authors:  N Barnea; Y Drory; A Iaina; C Lapidot; E Reisin; H Eliahou; J J Kellermann
Journal:  Isr J Med Sci       Date:  1980-01

6.  A comparison of gas exchange indices used to detect the anaerobic threshold.

Authors:  V J Caiozzo; J A Davis; J F Ellis; J L Azus; R Vandagriff; C A Prietto; W C McMaster
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-11

7.  Therapeutic benefits of exercise training for hemodialysis patients.

Authors:  A P Goldberg; E M Geltman; J M Hagberg; J R Gavin; J A Delmez; R M Carney; A Naumowicz; M H Oldfield; H R Harter
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

8.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

Authors:  J W Eschbach; J C Egrie; M R Downing; J K Browne; J W Adamson
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

9.  Ventilatory anaerobic threshold for evaluating exercise performance in children with congenital left-to-right intracardiac shunt.

Authors:  T Reybrouck; M Weymans; H Stijns; L G van der Hauwaert
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

10.  Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

Authors:  C G Winearls; D O Oliver; M J Pippard; C Reid; M R Downing; P M Cotes
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

View more
  7 in total

1.  Recombinant human erythropoietin: duplicate publication.

Authors:  B A Warady
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

Review 2.  Exercise for children with chronic kidney disease and end-stage renal disease.

Authors:  Emma L Clapp; Alan Bevington; Alice C Smith
Journal:  Pediatr Nephrol       Date:  2011-01-14       Impact factor: 3.714

3.  Exercise capacity and physical fitness in pediatric dialysis and kidney transplant patients.

Authors:  Patricia Painter; Joanne Krasnoff; Robert Mathias
Journal:  Pediatr Nephrol       Date:  2007-03-20       Impact factor: 3.714

4.  Intradialytic cycling in children and young adults on chronic hemodialysis.

Authors:  Fabio Paglialonga; Amalia Lopopolo; Rosalia Viviana Scarfia; Silvia Consolo; Maria Albina Galli; Simona Salera; Maria Rosa Grassi; Anna Brivio; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

5.  Anemia in pediatric dialysis patients in end-stage renal disease network 5.

Authors:  Jeffrey J Fadrowski; Susan L Furth; Barbara A Fivush
Journal:  Pediatr Nephrol       Date:  2004-07-06       Impact factor: 3.714

6.  Recombinant erythropoietin (Epogen) improves cardiac exercise performance in children with end-stage renal disease.

Authors:  G R Martin; J R Ongkingo; M E Turner; E S Skurow; E J Ruley
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

Review 7.  Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review.

Authors:  Gordon Bruce; Peter Schulga; Ben C Reynolds
Journal:  Clin Kidney J       Date:  2022-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.